HCPCS Level II · retired code
J9199 — Injection, gemcitabine hydrochloride (infugem), 200 mg
J9199 was retired on Jun 30, 2020
CMS ended J9199 after Jun 30, 2020. Don’t report it for later dates of service. Current codes for the same drug:
- J9183Gemcitabine intravesical system, 225 mg
- J9184Injection, gemcitabine hydrochloride (avyxa), 200 mg
- J9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
- J9198Injection, gemcitabine hydrochloride, (infugem), 100 mg
- J9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
Code
CMS HCPCS fileHCPCS codeJ9199
Billing unit200 mg
- Descriptor
- Injection, gemcitabine hydrochloride (infugem), 200 mg
- Short descriptor
- Injection, infugem, 200 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jul 1, 2020
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Find the NDC
Med-Code hasn’t mapped J9199 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
J9199: common questions
- Is J9199 a CPT code?
- No. J9199 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is one billing unit of J9199?
- One unit of J9199 is 200 mg, as stated in the code's descriptor. Units to report = dose given ÷ 200 mg. J-code billing units.